Dopaminergic Enhancement of Learning and Memory in Aphasia

NCT00102869 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Cerebrovascular Accident
Aphasia

Interventions

DRUG: levodopa

Sponsor

University Hospital Muenster

Collaborators

[object Object]